TECX — Tectonic Therapeutic Balance Sheet
0.000.00%
- $406.01m
- $265.64m
- 34
- 23
- 37
- 22
Annual balance sheet for Tectonic Therapeutic, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 28.1 | 36 | 28.8 | 141 |
Prepaid Expenses | ||||
Total Current Assets | 28.6 | 37 | 30.9 | 147 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 3.66 | 9.55 | 7.23 | 5.3 |
Other Long Term Assets | ||||
Total Assets | 32.9 | 47.2 | 39.4 | 153 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 4.12 | 7.84 | 40.9 | 11.6 |
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 5.23 | 12.2 | 43.4 | 12.1 |
Redeemable Preferred Stock | ||||
Non Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 27.6 | 35 | -4.01 | 141 |
Total Liabilities & Shareholders' Equity | 32.9 | 47.2 | 39.4 | 153 |
Total Common Shares Outstanding |